Detalhe da pesquisa
1.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331369
2.
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?
Curr Treat Options Oncol
; 24(2): 76-92, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656505
3.
Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second-Line Treatment for Patients with Metastatic Colorectal Cancer.
Oncologist
; 26(2): e261-e269, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191588
4.
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
N Engl J Med
; 378(13): 1177-1188, 2018 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590544
5.
FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer.
Future Oncol
; 17(24): 3151-3162, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993740
6.
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
Lancet Oncol
; 21(12): 1620-1629, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271092
7.
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 20(6): 849-861, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31003911
8.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Oncologist
; 24(2): 185-192, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190299
9.
The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective.
Curr Treat Options Oncol
; 20(1): 8, 2019 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30684093
10.
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
N Engl J Med
; 372(20): 1909-19, 2015 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25970050
11.
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Lancet Oncol
; 16(8): 937-48, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26184520
12.
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research.
J Med Ethics
; 41(10): 799-803, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26066362
13.
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet
; 381(9863): 303-12, 2013 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23177514
14.
Optimizing treatment outcomes with regorafenib: personalized dosing and other strategies to support patient care.
Oncologist
; 19(6): 669-80, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821824
15.
Cross-trial comparisons for the adjuvant treatment of MSI colorectal cancer: dare to dream the future scenarios.
Eur J Cancer
; 199: 113538, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278008
16.
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts.
Eur J Cancer
; 206: 114118, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38810317
17.
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
J Clin Oncol
; : JCO2301326, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547438
18.
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Cancer Immunol Immunother
; 62(6): 1041-52, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591981
19.
From trial highlights to clinical context: putting American Society of Clinical Oncology gastrointestinal news into practice.
Future Oncol
; 9(5): 645-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23647293
20.
Reliability of patient-reported toxicities during adjuvant chemotherapy.
Eur J Cancer
; 182: 115-121, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758476